Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Obtains Distribution Rights to Qiagen's PCR Kits for HLA Typing

NEW YORK (GenomeWeb News) – Dutch molecular diagnostics company GenDx announced today that Qiagen has granted it non-exclusive rights for the worldwide distribution for Qiagen's LongRange PCR kit in combination with GenDx's SBTexcellerator reagents for high-resolution HLA typing.

The agreement covers both direct distribution by GenDx as well as third-party distribution.

The combination of the LongRange PCR kit and SBTexcellerator reagents allows researchers to amplify HLA genes beyond the exon 2, 3, and 4 regions, making it possible to identify by sequencing other important regions of HLA genes, GenDx said.

"This distribution agreement enables GenDx and [its] partners to even better fulfill the requirements of our customers worldwide to efficiently obtain reliable HLA-typing results," Wietse Mulder, managing director for GenDx, said in a statement.

SBTexcellerator reagents received CE Marking in September for high-resolution HLA typing. GenDx and Qiagen have an ongoing collaboration to develop and commercialize products for HLA testing, and Qiagen is the exclusive worldwide distributor for the SBT reagent line.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.